Karyopharm Therapeutics (KPTI)
(Real Time Quote from BATS)
$0.92 USD
-0.01 (-0.76%)
Updated Jun 5, 2024 10:28 AM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Karyopharm Therapeutics Inc. [KPTI]
Reports for Purchase
Showing records 381 - 386 ( 386 total )
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov 17
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Q3:14 Earnings, KPTI Continuing to Aggressively Pursue Clinical Development of Selinexor, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov 10
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Company: Karyopharm Therapeutics Inc.
Industry: Medical - Drugs
Initiating Coverage with an OUTPERFORM Rating and $50 Price Target, Novel Broad-Spectrum Anti-Tumor Inhibition of Nuclear Export
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D